INVENTRONICS LTD (IVX.CA) Stock Fundamental Analysis

TSX-V:IVX • CA4612082095

0.77 CAD
+0.01 (+1.32%)
Last: Feb 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, IVX scores 5 out of 10 in our fundamental rating. IVX was compared to 4 industry peers in the Building Products industry. IVX scores excellent on profitability, but there are some minor concerns on its financial health. IVX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • IVX had positive earnings in the past year.
  • In the past year IVX had a positive cash flow from operations.
  • Of the past 5 years IVX 4 years were profitable.
  • In the past 5 years IVX always reported a positive cash flow from operatings.
IVX.CA Yearly Net Income VS EBIT VS OCF VS FCFIVX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M

1.2 Ratios

  • IVX's Return On Assets of 3.06% is amongst the best of the industry. IVX outperforms 100.00% of its industry peers.
  • IVX has a Return On Equity of 7.03%. This is amongst the best in the industry. IVX outperforms 100.00% of its industry peers.
  • IVX has a better Return On Invested Capital (5.32%) than 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for IVX is significantly above the industry average of 5.32%.
  • The last Return On Invested Capital (5.32%) for IVX is well below the 3 year average (16.93%), which needs to be investigated, but indicates that IVX had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.06%
ROE 7.03%
ROIC 5.32%
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
IVX.CA Yearly ROA, ROE, ROICIVX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.38%, IVX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • IVX has a Operating Margin of 4.99%. This is amongst the best in the industry. IVX outperforms 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of IVX has declined.
  • IVX's Gross Margin of 19.10% is in line compared to the rest of the industry. IVX outperforms 50.00% of its industry peers.
  • In the last couple of years the Gross Margin of IVX has declined.
Industry RankSector Rank
OM 4.99%
PM (TTM) 2.38%
GM 19.1%
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
IVX.CA Yearly Profit, Operating, Gross MarginsIVX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • IVX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for IVX remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, IVX has more shares outstanding
  • The debt/assets ratio for IVX has been reduced compared to a year ago.
IVX.CA Yearly Shares OutstandingIVX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
IVX.CA Yearly Total Debt VS Total AssetsIVX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • An Altman-Z score of 2.73 indicates that IVX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of IVX (2.73) is comparable to the rest of the industry.
  • IVX has a debt to FCF ratio of 4.04. This is a neutral value as IVX would need 4.04 years to pay back of all of its debts.
  • IVX has a worse Debt to FCF ratio (4.04) than 75.00% of its industry peers.
  • IVX has a Debt/Equity ratio of 0.77. This is a neutral value indicating IVX is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.77, IVX is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 4.04
Altman-Z 2.73
ROIC/WACC0.62
WACC8.55%
IVX.CA Yearly LT Debt VS Equity VS FCFIVX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.3 Liquidity

  • A Current Ratio of 2.65 indicates that IVX has no problem at all paying its short term obligations.
  • The Current ratio of IVX (2.65) is better than 75.00% of its industry peers.
  • IVX has a Quick Ratio of 1.88. This is a normal value and indicates that IVX is financially healthy and should not expect problems in meeting its short term obligations.
  • IVX has a better Quick ratio (1.88) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 1.88
IVX.CA Yearly Current Assets VS Current LiabilitesIVX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 825.93% over the past year.
  • IVX shows a strong growth in Revenue. In the last year, the Revenue has grown by 35.07%.
  • IVX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.21% yearly.
EPS 1Y (TTM)825.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%259.38%
Revenue 1Y (TTM)35.07%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%29.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVX.CA Yearly Revenue VS EstimatesIVX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 19.25 indicates a rather expensive valuation of IVX.
  • Compared to the rest of the industry, the Price/Earnings ratio of IVX indicates a rather cheap valuation: IVX is cheaper than 100.00% of the companies listed in the same industry.
  • IVX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.25
Fwd PE N/A
IVX.CA Price Earnings VS Forward Price EarningsIVX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IVX is valued cheaper than 100.00% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IVX indicates a rather cheap valuation: IVX is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.6
EV/EBITDA 8.39
IVX.CA Per share dataIVX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The decent profitability rating of IVX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 23.33%, IVX is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 7.78, IVX pays a better dividend. On top of this IVX pays more dividend than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, IVX pays a better dividend.
Industry RankSector Rank
Dividend Yield 23.33%

5.2 History

  • IVX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IVX.CA Yearly Dividends per shareIVX.CA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
IVX.CA Yearly Income VS Free CF VS DividendIVX.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K 1M 1.5M 2M

More info and screens

Find the best dividend stocksShow peers with best dividend

INVENTRONICS LTD

TSX-V:IVX (2/11/2026, 7:00:00 PM)

0.77

+0.01 (+1.32%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.93%
Ins Owner ChangeN/A
Market Cap3.75M
Revenue(TTM)8.02M
Net Income(TTM)191.00K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 23.33%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 19.25
Fwd PE N/A
P/S 0.47
P/FCF 6.6
P/OCF 5.93
P/B 1.38
P/tB 1.38
EV/EBITDA 8.39
EPS(TTM)0.04
EY5.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.12
FCFY15.15%
OCF(TTM)0.13
OCFY16.85%
SpS1.65
BVpS0.56
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.71
Profitability
Industry RankSector Rank
ROA 3.06%
ROE 7.03%
ROCE 7.89%
ROIC 5.32%
ROICexc 6.85%
ROICexgc 6.85%
OM 4.99%
PM (TTM) 2.38%
GM 19.1%
FCFM 7.08%
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
ROICexc(3y)18.71%
ROICexc(5y)18%
ROICexgc(3y)18.71%
ROICexgc(5y)18%
ROCE(3y)25.1%
ROCE(5y)24.63%
ROICexgc growth 3Y-68.88%
ROICexgc growth 5Y-39.12%
ROICexc growth 3Y-68.88%
ROICexc growth 5Y-39.12%
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
F-Score7
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 4.04
Debt/EBITDA 3.59
Cap/Depr 34.41%
Cap/Sales 0.8%
Interest Coverage 2.86
Cash Conversion 107.85%
Profit Quality 297.38%
Current Ratio 2.65
Quick Ratio 1.88
Altman-Z 2.73
F-Score7
WACC8.55%
ROIC/WACC0.62
Cap/Depr(3y)281.39%
Cap/Depr(5y)239.45%
Cap/Sales(3y)5.39%
Cap/Sales(5y)4.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)825.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%259.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.07%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%29.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y250.88%
EBIT growth 3Y-69.33%
EBIT growth 5Y-34.39%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.83%
FCF growth 3Y-16.33%
FCF growth 5Y11.05%
OCF growth 1Y-75.44%
OCF growth 3Y-11.65%
OCF growth 5Y14.04%

INVENTRONICS LTD / IVX.CA FAQ

What is the ChartMill fundamental rating of INVENTRONICS LTD (IVX.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to IVX.CA.


What is the valuation status for IVX stock?

ChartMill assigns a valuation rating of 4 / 10 to INVENTRONICS LTD (IVX.CA). This can be considered as Fairly Valued.


How profitable is INVENTRONICS LTD (IVX.CA) stock?

INVENTRONICS LTD (IVX.CA) has a profitability rating of 7 / 10.


What is the valuation of INVENTRONICS LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for INVENTRONICS LTD (IVX.CA) is 19.25 and the Price/Book (PB) ratio is 1.38.


Is the dividend of INVENTRONICS LTD sustainable?

The dividend rating of INVENTRONICS LTD (IVX.CA) is 5 / 10 and the dividend payout ratio is 0%.